Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
128.71
-9.63 (-6.96%)
Aug 21, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
34,07124,53816,49414,01410,00814,112
Market Cap Growth
22.67%48.77%17.70%40.02%-29.08%-9.11%
Enterprise Value
32,41423,57815,21312,6589,44313,028
Last Close Price
128.7192.7062.3152.9441.7058.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
67.6535.5135.5135.5135.51-
PS Ratio
20.7730.2830.9536.2633.1174.13
PB Ratio
19.8022.7113.178.5212.7111.26
P/TBV Ratio
20.0923.3713.708.9614.9813.07
P/OCF Ratio
42.76-431.73---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
19.7629.0928.5432.7631.2468.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.471.050.830.540.700.18
Net Debt / Equity Ratio
-0.96-0.83-0.92-0.83-0.63-0.78
Net Debt / EBITDA Ratio
-3.344.476.653.821.032.11
Net Debt / FCF Ratio
-2.574.2720.094.601.091.86
Asset Turnover
0.500.270.180.170.180.10
Inventory Turnover
0.610.460.260.300.370.19
Quick Ratio
2.261.541.712.081.573.35
Current Ratio
2.501.711.882.221.773.69
Return on Equity (ROE)
38.00%-14.16%-10.37%-24.27%-47.59%-31.38%
Return on Assets (ROA)
8.80%-5.08%-4.60%-10.91%-19.70%-17.02%
Return on Capital Employed (ROCE)
19.60%-15.80%-13.30%-22.70%-57.30%-37.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
1.61%-0.66%-0.84%-1.99%-4.57%-3.20%
FCF Yield
1.89%-0.86%-0.35%-2.11%-4.59%-3.72%
Buyback Yield / Dilution
-1.16%0.85%-3.71%-6.74%0.19%-2.20%